ABBV earnings: next report 2026-07-31, real EPS beat/miss history, analyst consensus Buy, P/E 124.20. Updated 2026-07-23.
AbbVie (ABBV) Research Hub
AbbVie (ABBV) trades on NYSE, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-09-11, shares last closed at 257.06 USD (+2.45%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 124.20, market cap 450.46B. This hub links to the full technical, earnings and options research available for ABBV.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, US |
| Last close | 257.06 USD (+2.45%) |
| 52-week range | 218.83 USD – 267.47 USD |
| Trend regime | Range |
| 14-day RSI | 59.6 (Bullish) |
| Trailing P/E | 124.20 |
| Market cap | 450.46B |
| Dividend yield | 2.70% |
| Next earnings | 2026-07-31 |
Available research for ABBV
Covered Call on ABBV: how it works, illustrative setup around the real 257.06 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABBV: how it works, illustrative setup around the real 257.06 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABBV: how it works, illustrative setup around the real 257.06 USD price, max profit/loss, breakeven and when to use it. Educational.
ABBV technical analysis: range, last 257.06 USD, RSI 59.6, 52w range 218.83 USD–267.47 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ABBV in?
AbbVie (ABBV) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, US.
Is ABBV in an uptrend or downtrend?
As of 2026-09-11, ABBV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABBV's trailing P/E ratio?
ABBV's trailing P/E is 124.20, with a market cap of 450.46B. See the earnings research page for full valuation detail.
When does ABBV next report earnings?
ABBV is next scheduled to report earnings on 2026-07-31, with a consensus EPS estimate of 3.62 USD.